Results 91 to 100 of about 13,535 (197)

Clinical features and management for CDK4/6 inhibitor-DILI. [PDF]

JHEP Rep
Riveiro-Barciela M, Esteban P, Vega-Cano KS, Mateos B, Miranda EL, Jara P, Martín M, Alonso López S, Salcedo M, Forns X, García-Fructuoso I, Martínez-Sáez O, Pinazo-Bandera J, García-Cortés M, Ribelles N, Romanos Nanclares Á, Morchón-Araujo D, Rodríguez CA, Lozano R, Domínguez-Gómez R, Cejuela M, Torres-Sempere J, Ruiz-Cobo JC, Villagrasa A, Zamora E, Buti M, Bellet M.   +26 more
europepmc   +1 more source

Drug-induced liver injury due to potassium iodide during thyroid storm. [PDF]

JCEM Case Rep
Takano N, Seki Y, Watanabe D, Ichihara A.   +3 more
europepmc   +1 more source

Efficacy and safety of glucocorticoids for acute drug-induced liver injury with hyperbilirubinemia: protocol of a multicenter randomized controlled trial. [PDF]

Ther Adv Gastroenterol
Li Q, Lin Y, Zeng X, Zhou L, Wang F, Ye Q, Gao Y, Guo L, Zhu J, Li J, Li Y, Shao L, Hu Y, Xiao J, Jia A, Wang D, Chang L, Wang J, Zhang J, Wang R, Gao F, Wu Q, Hu P, Zhu C, Cai L, Ran Y, Li Y, Zhang J, Ran Y, Wang C, Wang N, Zhang J, Zhang X, Li J, Sun J, Chu Y, Ma Y, Wang T, Zheng Z, Shen Y, Qi X, Xie W.   +41 more
europepmc   +1 more source

Avacopan-Associated Hepatotoxicity: Clinical Signal, Liver Injury Patterns, and Plausible Mechanisms. [PDF]

Cureus
Herrera-Jiménez LG, Arguedas-Chacón S, Mora-Jiménez J, Zavaleta-Monestel E.   +3 more
europepmc   +1 more source

Costs, Demographics, and Causative Agents in Patients Hospitalized for Drug Induced Liver Injury: Trends in a Large Academic Healthcare System. [PDF]

Clin Exp Gastroenterol
Kozar M, Gonzalez Y, Halegoua-DeMarzio D.   +2 more
europepmc   +1 more source

Meropenem-Induced Possible Mixed Drug-Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016). [PDF]

Clin Case Rep
Mutawodeh N, Saife S, Shalaby A, Einar K, Kamal M, Hijaz M, Hamadneh T.   +6 more
europepmc   +1 more source

Risk factors for drug-induced liver injury in tuberculosis patients: a meta-analysis and systematic review. [PDF]

Front Med (Lausanne)
Liu X, Liu C, Yao R, Wan B, Fu L, Yang X, Zhang Y, Du J, Long X.   +8 more
europepmc   +1 more source

Network Pharmacology Analysis Reveals Multi-Target Hepatoprotective Mechanisms of a Multi-Component Pharmacopuncture Against Ephedra-Associated Liver Injury with Implications for Mitochondrial Quality Control. [PDF]

Medicina (Kaunas)
Hwang JH, Jung C.
europepmc   +1 more source

Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy. [PDF]

Liver Int
Kirchner T, Dalekos GN, Zachou K, Robles-Díaz M, Andrade RJ, Sebode M, Lohse A, Janik MK, Milkiewicz P, Kolev M, Semmo N, Bruns T, Gevers TJ, Beretta-Piccoli BT, Wedemeyer H, Jaeckel E, Taubert R, Engel B, pIgG study group.   +18 more
europepmc   +1 more source

Aspartate aminotransferase and model for end-stage liver disease reliably predict mortality in drug-induced liver injury. [PDF]

Sci Rep
Weber S, Mircheva I, Balakumar R, Allgeier J, Saka D, Donga N, Lange CM, Gerbes AL.   +7 more
europepmc   +1 more source